Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
World Stock Indices Examples presents representative benchmarks from major economies to illustrate global market movements.
22,492 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
When a company's CEO sells 31,000 shares worth roughly $1.41 million, it sparks questions for investors. This guide e...
A big multi-system order helped Camtek push its stock higher as investors weighed the implications for backlog, margi...
As memory cycles swing, the safest play in July may not be the pure-play chips you expect. This article explains why ...
A large hedge fund reduced its stake in InterDigital (IDCC) by selling 125,230 shares, worth about $44.28 million. Th...
A standout quarterly report helped Rhythm Pharmaceuticals stock surge on Tuesday as investors embraced better-than-ex...
As AI accelerates, a pair of blue-chip picks stands out for a decade-long hold. Learn why these two AI leaders fit th...
When a Galicia director just bought a large stake, investors ask: is this a signal of confidence or a red flag? This ...
Active fund moves can shake even steady income plays. This article breaks down why cushing asset management sells Hes...
Chevron has kept its promise to shareholders with steady cash returns. Discover how 16 quarters of returns totaling o...
Broadcom's AI outlook miss triggered a pronounced one-day pullback, signaling investor caution around AI-driven growt...
As vernova's next earnings report approaches, traders and long-term investors weigh margin trends, project momentum, ...